Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $699M bought by 128 insiders at 87 companies
- $1.3B sold by 80 insiders outside a trading plan
- $1B sold by 336 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past week · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$247M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.4M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$66.3M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$62M
-
GMEGameStop CorporationRyan CohenCEO$17.1M
-
AVRAnteris Technologies Global Corp.L1 Capital Pty Ltd10% owner$9.7M
-
BORRBorr Drilling LimitedTor Olav TroimDirector$6.2M
-
PAMPampa Energia S.A.Damian Miguel MindlinVicepresident$5.6M
-
GPUSHyperscale Data, Inc.Milton C Ault IIIChair · +1 joint filer$5.1M
Biggest sales
Past week · by insider, all their filings added up · planned sales marked
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
NBISNebius Group N.V.Ophir NaveCOO$118M
-
CBRSCerebras Systems Inc.Dhiraj MallickCOO$80.8M
-
CRWDCrowdStrike Holdings, Inc.Michael SentonasPresident$64.2M
-
AAPLApple Inc ComTimothy D CookChair$63.8M
-
MPWRMonolithic Power Systems, Inc.Michael HsingCEO$40.3M
-
ACTEnact Holdings, Inc.Genworth Holdings, Inc.10% owner$37.1M
-
WDAYWorkday, Inc.David A Duffield10% owner$37.1M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Yuen Wupen President, Global Bus. UnitsLITELumentum Holdings Inc.Planned sale$764K 807 shares at $947.17 0.7% of stakeTraded Sep 28–29 Filed Sep 30
-
John R Gallagher COOTRUPTrupanion, Inc.Planned sale$9,879 431 shares at $22.92 1.3% of stakeTraded Sep 28 Filed Sep 30
-
Peter Altman CEOBCDABioCardia, Inc.Buy$1,030 1,000 shares at $1.03 +0.3% to stakeTraded Sep 29 Filed Sep 30
-
Robert Patrick Komin Jr. CFOCBRSCerebras Systems Inc.Planned sale$6.6M 32,500 shares at $203.53 100% of stakeTraded Sep 29 Filed Sep 30
-
Dhiraj Mallick COOCBRSCerebras Systems Inc.Planned sale$80.8M 396,000 shares at $204.04 100% of stakeTraded Sep 29 Filed Sep 30
-
Yagnesh Patel Chief Accounting OfficerCBRSCerebras Systems Inc.Planned sale$270K 1,320 shares at $204.50 7.9% of stakeTraded Sep 28 Filed Sep 30
-
Javier Olivan COOMETAMeta Platforms, Inc., Class APlanned sale$1.2M 1,575 shares at $749.82Traded Sep 28 Filed Sep 30
-
Caton Frates Sr. Executive Vice PresidentCOSTCostco Wholesale CorporationSale$733K 801 shares at $915.93 9.2% of stakeTraded Sep 29 Filed Sep 30
-
Jacob Bistricer COOCLPRClipper Realty Inc.Buy$246K 73,500 shares at $3.35 New stakeTraded Sep 28 Filed Sep 30
-
Claudine Adamo Executive Vice PresidentCOSTCostco Wholesale CorporationSale$2M 2,200 shares at $915.93 24% of stakeTraded Sep 29 Filed Sep 30
-
Artur Bergman Chief Technology OfficerFSLYFastly, Inc.Planned sale$919K 37,039 shares at $24.81 3.3% of stakeTraded Sep 28–29 Filed Sep 30
-
Laura Lee Stewart CEOSFBCSound Financial Bancorp, Inc.Planned sale$41K 900 shares at $45.99 10% of stakeTraded Sep 30 Filed Sep 30
-
Michael Hsing CEOMPWRMonolithic Power Systems, Inc.Planned sale$40.3M 30,000 shares at $1,344.97 3.5% of stakeTraded Sep 28 Filed Sep 30
-
Mauro Stocchi See RemarksSTVNStevanato Group S.p.A.Sale$293K 13,649 shares at $21.50 3.3% of stakeTraded Sep 28 Filed Sep 30
-
Na Li CFOLHAILinkhome Holdings Inc.Sale$45K 30,000 shares at $1.50 100% of stakeTraded Apr 28 Filed Sep 30
-
Chasity D Grosh See RemarksPFGCPerformance Food Group CompanyPlanned sale$93K 1,005 shares at $92.40 15% of stakeTraded Sep 30 Filed Sep 30
-
John Taylor Maloney Fitzgerald CEOKWYKingsway CorporationBuy$2,502 269 shares at $9.30 +<0.1% to stakeTraded Sep 30 Filed Sep 30
-
Kent A Hansen CFOKWYKingsway CorporationBuy$1,572 169 shares at $9.30 +0.1% to stakeTraded Sep 30 Filed Sep 30
-
D James Bidzos CEOVRSNVerisign Inc.Planned sale$920K 3,300 shares at $278.78 0.9% of stakeTraded Sep 29 Filed Sep 30
-
Stephen P. Carey CFOANIPANI Pharmaceuticals, Inc.Planned sale$208K 2,850 shares at $73.00 1.7% of stakeTraded Sep 29 Filed Sep 30
-
Sergey Losyev Co-Chief Investment OfficerARRARMOUR Residential REIT, Inc.Buy$10K 725 shares at $13.91 +8.1% to stakeTraded Sep 29 Filed Sep 30
-
Todd M Duchene See remarksCORZCore Scientific, Inc.Planned sale$168K 10,000 shares at $16.76 0.8% of stakeTraded Sep 28 Filed Sep 30
-
Marshall Urist EVP, Research & InvestmentsRPRXRoyalty Pharma plcPlanned sale$239K 4,126 shares at $57.88 50% of stakeTraded Sep 28 Filed Sep 30
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.5M 9,500 shares at $477.42 2.8% of stakeTraded Sep 29 Filed Sep 30
-
Nathan Blecharczyk Chief Strategy OfficerABNBAirbnb Inc.Planned sale$2.1M 13,615 shares at $156.82 40% of stakeTraded Sep 28 Filed Sep 30
-
William B. Horne CEOGPUSHyperscale Data, Inc.Buy$16K 100,000 shares at $0.1600 +25% to stakeTraded Sep 30 Filed Sep 30
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6.5M 66,000 shares at $98.19 24% of stakeTraded Sep 29–30 Filed Sep 30
-
Robert D Vilsack Secretary & CLOPKOHPark-Ohio Holdings Corp.Planned sale$427K 9,000 shares at $47.44 5.1% of stakeTraded Sep 28 Filed Sep 30
-
Jose Minaya Senior Executive VPBNYThe Bank of New York Mellon Corp.Planned sale$524K 3,520 shares at $148.79 2% of stakeTraded Sep 28 Filed Sep 30
-
Sadie Stern EVP Chief People & Culture OffDXCMDexCom, Inc.Planned sale$221K 2,565 shares at $86.15 2% of stakeTraded Sep 28 Filed Sep 30
-
Nima Ghamsari Head of BlendBLNDBlend Labs, Inc.Planned sale$25K 22,523 shares at $1.10 0.3% of stakeTraded Sep 28 Filed Sep 30
-
Prabir Adarkar COODASHDoorDash, Inc.Planned sale$1.6M 8,738 shares at $180.85 0.9% of stakeTraded Sep 28 Filed Sep 30
-
Robert D Vilsack Secretary & CLOPKOHPark-Ohio Holdings Corp.Planned sale$337K 7,188 shares at $46.94 3.9% of stakeTraded Sep 28 Filed Sep 30
-
Richard Barry CEOFLNAFilana Therapeutics, Inc.Buy$78K 93,091 shares at $0.8400 +9.9% to stakeTraded Sep 28 Filed Sep 30
-
Kevin J McNamara CEOCHEChemed Corp.Sale$1M 2,000 shares at $513.45 2.9% of stakeTraded Sep 28 Filed Sep 30
-
Kyle Malady EVP and Group CEO-VZ BusinessVZVerizon Communications Inc.Planned sale$51K 1,100 shares at $46.40 1.1% of stakeTraded Sep 29 Filed Sep 30
-
Richard H Moore CEOFBNCFirst BancorpSale$1.5M 23,343 shares at $62.85 22% of stakeTraded Sep 28–29 Filed Sep 30
-
Yair Nechmad ChairNYAXNayax Ltd.Buy$2.1M 46,935 shares at $44.90 +0.6% to stakeTraded Sep 28–29 Filed Sep 30
-
Michael Catelani CFOANIXAnixa Biosciences, Inc.Buy$16K 5,500 shares at $2.84 +12% to stakeTraded Sep 30 Filed Sep 30
-
Robert George Culp IV CEOCULPCulp, Inc.Buy$12K 2,960 shares at $3.89 +2.2% to stakeTraded Sep 28 Filed Sep 30
-
Kun Dai CEOUXINUxin LimitedBuy$11K 8,440 shares at $1.26 New stakeTraded Sep 29 Filed Sep 30
-
Joseph P. Davy CEOPARABanzai International, Inc.Buy— 115,965 shares +343% to stakeTraded Sep 28 Filed Sep 30
-
Jingjing Eason Zhang CFOMNSOMINISO Group Holding LimitedBuy$340K 150,600 shares at $2.26 +62% to stakeTraded Sep 29 Filed Sep 30
-
Philip Andrew Smith CEOSNEXStoneX Group Inc.Planned sale$3.7M 56,250 shares at $65.69 7.1% of stakeTraded Sep 28 Filed Sep 29
-
Han Kyung Park SVP & GM of FPD OpsPLABPhotronics, Inc.Sale$289K 9,500 shares at $30.37 13% of stakeTraded Sep 25 Filed Sep 29
-
Michael Feld EVP, Chief Revenue OfficerBDXBecton, Dickinson and CompanyPlanned sale$14K 76 shares at $183.70 0.4% of stakeTraded Sep 28 Filed Sep 29
-
Joseph Cumello EVP & General Mgr.CIENCiena CorporationPlanned sale$569K 1,586 shares at $358.52 3.9% of stakeTraded Sep 25 Filed Sep 29
-
Dominic Piscitelli CFOORICOric Pharmaceuticals, Inc.Planned sale$181K 13,400 shares at $13.53 16% of stakeTraded Sep 28 Filed Sep 29
-
Jayshree Ullal CEOANETArista Networks, Inc.Planned sale$13.2M 62,622 shares at $211.40 0.4% of stakeTraded Sep 25 Filed Sep 29
-
Adam Eltoukhy See RemarksIOTSamsara Inc.Planned sale$285K 7,306 shares at $39.07 1.9% of stakeTraded Sep 25 Filed Sep 29
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.